CaixaBank, S.A.’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIB
RIA
BA
BRC
CaixaBank, S.A.'s BIB Position: Q1 2017 in Review
CaixaBank, S.A. sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q1 2017, closing a stake of 352 shares — an estimated $14K sold.
CaixaBank, S.A. first reported a position in BIB in Q4 2016 and held it in 1 quarter. The position peaked at $14K in Q4 2016. 28 funds tracked by Wall St. Rank hold BIB as of Q1 2017.
- CaixaBank, S.A. reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q1 2017 after selling out during the quarter.
- CaixaBank, S.A. sold 352 ProShares Ultra NASDAQ Biotechnology shares in Q1 2017, an estimated $14K.
- CaixaBank, S.A. first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2016 and held it in 1 quarter.
- CaixaBank, S.A.'s ProShares Ultra NASDAQ Biotechnology position peaked at $14K in Q4 2016.
- 28 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2017.
Based on CaixaBank, S.A.'s 13F filing for Q1 2017, filed 16 Nov 2026.